Loading startup
Market data is refreshed once per day from public sources. Information may be incomplete or outdated — verify independently before making decisions. This is not investment advice.
Evidence-bound summary — expand sections for movement, risks, and signals.
Memo snapshot · May 20, 2026, 6:31 PM
What would change this read
DealFlow OS uses public web data and automated enrichment. Research may be incomplete, outdated, or incorrect. Verify important information before making investment or outreach decisions.
TL;DR
Seed (YC)Nucleo | Automated Cancer Diagnostics Advanced AI for oncological medical imaging.
Raised $500K across 1 funding round. Latest: $500K Pre-seed (Jan 2025). Investors: Y Combinator. (High).
Funding
Raised $500K across 1 funding round. Latest: $500K Pre-seed (Jan 2025). Investors: Y Combinator. (High).
Product / news
1 product/news‑styled row(s); headline risk without filings (High).
Verified facts
Fall 2025 batch; agentic oncology platform for automated CT analysis.
Weak funding evidence: mention does not include a parsed raise amount/round and may refer to non-funding context.
No open roles indexed yet.
The index price and activity score are algorithmic estimates based on observed public company-level signals. They may be incomplete, stale, or inaccurate and are not investment, legal, tax, or business advice.
Source types found
Strongest / recent news-style rows
Wed, May 20, 06:31 PM · confidence 88%high quality
gdelt_doc_api · Sun, Jun 28, 09:13 PM · confidence 70%medium quality
wikipedia · Sun, Jun 28, 09:13 PM · confidence 50%medium quality
Newest first · 12 event(s)
Source: official_site
Nucleo | Automated Cancer Diagnostics Product Partnerships Use cases Get started Get started Nucleo Y Combinator LinkedIn Twitter © 2026 Nucleo Research. All rights reserved. Website by skarlo Nucleo Y Combinator LinkedIn Twitter © 2026 Nucleo Research. All r…
Fall 2025 batch; agentic oncology platform for automated CT analysis.
Advanced AI for oncological medical imaging.
Source: npm_registry
20px React SVG icon components from Nucleo
Source: npm_registry
18px outline React SVG icon components from Nucleo UI Library
Source: npm_registry
24px React SVG icon components from Nucleo
Source: npm_registry
24px React SVG icon components from Nucleo
Source: npm_registry
18px fill React SVG icon components from Nucleo UI Library
Source: gdelt_doc_api
business-review.eu
YC launch with performance metrics vs manual segmentation.
2 row(s)
The company's own site — the authoritative description of what they sell and to whom. Marketing-controlled, so treat claims as positioning rather than verified traction.
Nucleo | Automated Cancer Diagnostics Product Partnerships Use cases Get started Get started Nucleo Y Combinator LinkedIn Twitter © 2026 Nucleo Research. All rights reserved. Website by skarlo Nucleo Y Combinator LinkedIn Twitter © 2026 Nucleo Research. All r…
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗Advanced AI for oncological medical imaging.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗4 row(s)
Third-party press coverage. Independent reporting corroborates company claims; repeated coverage across outlets is a momentum signal.
business-review.eu
Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗YC launch with performance metrics vs manual segmentation.
Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗1 row(s)
Funding announcements and investor-database records. The strongest public signal of capitalization: round, amount, and syndicate quality when disclosed.
Fall 2025 batch; agentic oncology platform for automated CT analysis.
Why it matters: Funding signal — Pre-Seed per this source; verify against the linked original before relying on it.
Open source ↗5 row(s)
Public engineering activity. Sustained commits, releases, and stars indicate real product development and, for dev tools, developer adoption.
20px React SVG icon components from Nucleo
Why it matters: Engineering signal — public repo activity evidences active development and possible developer adoption.
Open source ↗18px outline React SVG icon components from Nucleo UI Library
Why it matters: Engineering signal — public repo activity evidences active development and possible developer adoption.
Open source ↗24px React SVG icon components from Nucleo
Why it matters: Engineering signal — public repo activity evidences active development and possible developer adoption.
Open source ↗24px React SVG icon components from Nucleo
Why it matters: Engineering signal — public repo activity evidences active development and possible developer adoption.
Open source ↗18px fill React SVG icon components from Nucleo UI Library
Why it matters: Engineering signal — public repo activity evidences active development and possible developer adoption.
Open source ↗Sign in as an active team member to view private notes, watchlist controls, transcript evidence, and interaction history.